Adaptive signs deal with Pfizer worth up to $890 million for rheumatoid arthritis research - TradingView — Track All Markets

Reuters | Dec. 15, 2025, 8:53 a.m. | Original
Adaptive signs deal with Pfizer worth up to $890 million for rheumatoid arthritis research TradingView — Track All Markets
Impact Coatings Raises About SEK 26.6 Mln In Rights Issue - TradingView — Track All Markets Netflix says its position on deal with Warner Bros Discovery unchanged - Reuters